Hepatology
Showing 20 of 20 topics
A
-
Diagnose with fever, jaundice, and cholestasis plus imaging; start broad spectrum antibiotics and arrange early biliary drainage with ERCP based on severity.
-
Charcot triad (fever, jaundice, RUQ pain) ± hypotension/AMS suggests cholangitis. Start broad-spectrum antibiotics and obtain urgent biliary decompression (ERCP) in moderate-to-severe cases per Tokyo Guidelines; correct coagulopathy and fluids.
-
Defined by acute liver injury, coagulopathy, and encephalopathy in patients without prior cirrhosis; secure airway in advanced encephalopathy, treat acetaminophen toxicity with NAC, manage intracranial pressure risk, and transfer early to a transplant center.
-
Rapid hepatic dysfunction with INR ≥1.5 and encephalopathy in a non‑cirrhotic patient. Start IV N‑acetylcysteine even in non‑acetaminophen cases; manage cerebral edema with head elevation and hypertonic saline; avoid hypoxia/hypotension. Apply King’s College criteria early for transplant referral; evaluate etiologies (acetaminophen, viral, autoimmune, ischemic, Wilson).
-
Assess severity with Maddrey DF or MELD; treat severe disease with prednisolone if no contraindications and reassess response with the Lille score at day 7.
C
-
Perform diagnostic paracentesis on admission, restrict sodium, start spironolactone plus furosemide, and give albumin after large volume paracentesis.
D
-
Stop the offending agent, classify injury pattern with R ratio, exclude viral, autoimmune, and biliary causes, and consider NAC in early severe cases while reporting the event.
H
-
Screen for HBsAg and anti HBc before immunosuppression; start antiviral prophylaxis for high risk regimens such as anti CD20 therapy and continue for months after completion.
-
Treat precipitating causes, give lactulose to target two to three soft stools daily, and add rifaximin for recurrent episodes; protect airway in severe cases.
-
Neuropsychiatric dysfunction in cirrhosis. Exclude alternative causes, correct precipitants (GI bleed, infection, dehydration), and treat with lactulose titrated to 2–3 soft stools/day plus rifaximin for prevention of recurrence; counsel on protein intake and avoid sedatives.
-
Diagnose HRS AKI after excluding shock, nephrotoxins, and structural kidney disease; give albumin plus vasoconstrictor therapy such as terlipressin, norepinephrine, or midodrine with octreotide, and evaluate for transplant.
O
-
Differentiate intrahepatic versus extrahepatic cholestasis with labs and ultrasound first; use MRCP or ERCP for further definition and treat pruritus and fat soluble vitamin issues.
S
-
Provide antibiotic prophylaxis for prior SBP, during upper GI bleeding, and for selected high risk ascites; choose daily fluoroquinolone or trimethoprim sulfamethoxazole per local patterns.
-
In cirrhosis with ascites, diagnose when PMN count is 250 cells per mm3 or higher; start third generation cephalosporin and give IV albumin on days 1 and 3; begin prophylaxis after recovery.
-
In any cirrhotic with ascites and abdominal pain or encephalopathy, perform diagnostic paracentesis; PMN ≥250 cells/mm³ confirms SBP. Start cefotaxime or ceftriaxone promptly and give albumin on day 1 and 3 to prevent renal failure; begin long-term prophylaxis after recovery when indicated.
-
In cirrhosis with ascites, perform immediate diagnostic paracentesis. Treat SBP when PMN ≥250/µL with IV third-generation cephalosporin and give IV albumin (day 1: 1.5 g/kg; day 3: 1.0 g/kg) to prevent renal failure. Start lifelong prophylaxis after an episode.
V
-
Resuscitate with restrictive transfusion; start vasoactive drug and ceftriaxone early; urgent endoscopy with band ligation; consider TIPS for refractory bleeding.
-
In cirrhosis with hematemesis/melena, start vasoactive therapy (octreotide) and prophylactic antibiotics immediately, resuscitate with restrictive transfusion, and perform early endoscopy for band ligation. Use balloon tamponade as a bridge if uncontrollable hemorrhage and consider early TIPS for high‑risk or refractory bleeding.
-
Portal hypertensive bleeding in cirrhosis requires early vasoactive drugs, prophylactic antibiotics, and endoscopic band ligation; use restrictive transfusion strategy and consider TIPS for refractory or high‑risk cases.
W
-
Suspect in young patients with hemolysis, low alkaline phosphatase to bilirubin ratio, and low ceruloplasmin; arrange urgent transplant evaluation and start copper directed therapy as bridge.
No topics match your filters.